These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6758986)
61. An analysis of the glucagon response to hypoglycaemia in patients with type 1 diabetes and in healthy subjects. Liu D; Adamson U; Lins PE; Clausen-Sjöbom N Diabet Med; 1993 Apr; 10(3):246-54. PubMed ID: 8485956 [TBL] [Abstract][Full Text] [Related]
62. [Insulin reserve of insulin-dependent diabetics. Role of C-peptide in the hormonal balance in diabetes]. Dauzat J; Moinade S; Gaillard G; Glanddier Y; Gachon AM Presse Med; 1983 Sep; 12(32):1983-7. PubMed ID: 6225101 [TBL] [Abstract][Full Text] [Related]
63. Hormonal response during physical exercise of different intensities in adolescents with type 1 diabetes and healthy controls. Adolfsson P; Nilsson S; Albertsson-Wikland K; Lindblad B Pediatr Diabetes; 2012 Dec; 13(8):587-96. PubMed ID: 23173876 [TBL] [Abstract][Full Text] [Related]
64. Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Sjöberg S; Gunnarsson R; Gjötterberg M; Lefvert AK; Persson A; Ostman J Diabetologia; 1987 Apr; 30(4):208-13. PubMed ID: 3297896 [TBL] [Abstract][Full Text] [Related]
65. Metabolic results at 6 and 12 months after pancreas transplantation. Sousa-Castello A; Lefrancois N; Martin X; Caldara R; Pouteil-Noble C; Touraine JL; Dubernard JM Transplant Proc; 1992 Jun; 24(3):839. PubMed ID: 1604632 [No Abstract] [Full Text] [Related]
66. [Clinical significance of plasma C-peptide analysis and the analytical method in the diagnosis of diabetes related diseases]. Matsuda A Nihon Rinsho; 1990 Dec; 48 Suppl():284-92. PubMed ID: 2086901 [No Abstract] [Full Text] [Related]
67. Recent progress in the treatment of diabetic nephropathy: importance of strict glycemic control on the regression of diabetic nephropathy. Kawamori R; Kamado K; Kamada T J Diabet Complications; 1991; 5(2-3):88-90. PubMed ID: 1770063 [No Abstract] [Full Text] [Related]
68. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children. Sochett EB; Daneman D; Clarson C; Ehrlich RM Diabetologia; 1987 Jul; 30(7):453-9. PubMed ID: 3311859 [TBL] [Abstract][Full Text] [Related]
69. Free fatty acids level may effect a residual insulin secretion in type 1 diabetes. Zmysłowska A; Wyka K; Szadkowska A; Mianowska B; Pietrzak I; Młynarski W Pediatr Endocrinol Diabetes Metab; 2011; 17(1):26-9. PubMed ID: 21489353 [TBL] [Abstract][Full Text] [Related]
70. Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes. Jones AG; Besser RE; McDonald TJ; Shields BM; Hope SV; Bowman P; Oram RA; Knight BA; Hattersley AT Diabet Med; 2011 Sep; 28(9):1034-8. PubMed ID: 21843301 [TBL] [Abstract][Full Text] [Related]
71. Can GLP-1 preparations be used in children and adolescents with diabetes mellitus? Shehadeh N; Daich E; Zuckerman-Levin N Pediatr Endocrinol Rev; 2014 Mar; 11(3):324-7. PubMed ID: 24716398 [TBL] [Abstract][Full Text] [Related]
72. The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus. Frier BM; Faber OK; Binder C; Elliot HL Diabetologia; 1978 May; 14(5):301-4. PubMed ID: 348540 [TBL] [Abstract][Full Text] [Related]
73. Residual beta-cell function and metabolic stability in insulin-dependent diabetes mellitus. Nakamura H; Takagi A; Tsuda A; Momotsu T; Ito S; Shibata A Tohoku J Exp Med; 1988 May; 155(1):71-80. PubMed ID: 3046059 [TBL] [Abstract][Full Text] [Related]
74. Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes. Zander M; Taskiran M; Toft-Nielsen MB; Madsbad S; Holst JJ Diabetes Care; 2001 Apr; 24(4):720-5. PubMed ID: 11315837 [TBL] [Abstract][Full Text] [Related]
75. Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes. Gjessing HJ; Matzen LE; Faber OK; Frøland A Diabetologia; 1989 May; 32(5):305-11. PubMed ID: 2666217 [TBL] [Abstract][Full Text] [Related]
76. Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes. Max Andersen ML; Hougaard P; Pörksen S; Nielsen LB; Fredheim S; Svensson J; Thomsen J; Vikre-Jørgensen J; Hertel T; Petersen JS; Hansen L; Mortensen HB Pediatr Diabetes; 2014 Nov; 15(7):469-76. PubMed ID: 25287319 [TBL] [Abstract][Full Text] [Related]
77. Metabolic effect of islet B-cell function in insulin-treated diabetes. Gjessing HJ; Matzen LE; Iversen S; Faber OK; Frøland A Scand J Clin Lab Invest; 1989 Jun; 49(4):337-43. PubMed ID: 2662383 [TBL] [Abstract][Full Text] [Related]
78. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. Vaag A; Henriksen JE; Madsbad S; Holm N; Beck-Nielsen H J Clin Invest; 1995 Feb; 95(2):690-8. PubMed ID: 7860750 [TBL] [Abstract][Full Text] [Related]
79. Heterotopic pancreas transplantation does not necessarily confer basal hyperinsulinemia. Cantarovich D; Guillemet B; Cagliotti A; Murat A; Krempf M; Soulillou JP Transplant Proc; 1994 Apr; 26(2):475. PubMed ID: 8171512 [No Abstract] [Full Text] [Related]
80. Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed type 1 and type 2 diabetes. Ziegler D; Strom A; Bönhof G; Püttgen S; Bódis K; Burkart V; Müssig K; Szendroedi J; Markgraf DF; Roden M; Metabolism; 2018 Feb; 79():1-9. PubMed ID: 29113812 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]